CLINICAL SUPPLY MANAGEMENT ARTICLES
How Early Signals Prevent Risk In Clinical Trial Supply Chains
Small shifts in forecasts, RTSM behavior, and inventory can reveal future supply risks. Learn how early signals help clinical teams prevent disruptions before they escalate.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Learn why an RTSM solution should be adaptive and flexible, and should help clinical trial teams uncover the best ways to handle protocol amendments.
-
Patient enrollment can vary widely due to a number of variables, introducing risk into the supply chain. Here's why its critical to be aware of these risks and how best to mitigate them within trials.
-
Rachel Curran, Head of Sourcing Services and Special Accounts, discusses the requirements, challenges, and solutions to comparator and co-therapy drug sourcing for clinical trials.
-
Recently, there has been a lot of messaging around agility in Randomization and Trial Supply Management (RTSM) or as some refer to it, Interactive Response Technology (IRT). Is “agile” becoming the new “innovative”? Find out more in this white paper.
-
Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.
-
Examine how the next generation of therapies is disrupting supply chain logistics and explore solutions for the complexities within cell and gene therapies.
-
Investing in employee training and development is not just beneficial for the employees. It also contributes significantly to the organization’s success and competitive advantage.